RxDoctor Payments Data

Linda Burkett, MD

Urogynecology and Reconstructive Pelvic Surgery · Henrico, VANPI 1982022877

Payments from drug & device makers

What this record shows

6 manufacturers reported payments, led by Intuitive Surgical at 58.4% of the total. Reporting peaked in 2021 at $1,029 and has fallen 88.3% since, to $121 in 2025. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in VA, where the typical reported total is $3,461.

$1,761in general payments, 2019–2025

Across 13 payments — averaging $135.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$1K
  • Medtronic$191
  • Asensus Surgical, Inc.$176
  • AbbVie$143
  • Axonics, Inc.$116
  • Coloplast$106

What the payments were for

  • Food & beverage$76143%
  • Education$1,00057%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical2$1,029
Medtronic(2 entities)3$191
Asensus Surgical, Inc.4$176
AbbVie(2 entities)2$143
Axonics, Inc.1$116
Coloplast1$106

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,761 in reported general payments places this provider in the 35th percentile of 29 urogynecology and reconstructive pelvic surgery providers in Virginia.

See all urogynecology and reconstructive pelvic surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$89,474
Medicare patients
128
Services billed
2,651

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron117$84,354
Mirabegron ErMirabegron26$12,315
Estradiol80$6,358
PremarinEstrogens, Conjugated12$5,121
Solifenacin Succinate41$959
Oxybutynin Chloride ErOxybutynin Chloride23$939
Trospium Chloride13$905
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst55$881
Methenamine Hippurate11$793
Cephalexin40$526
Metronidazole11$392
Nystatin-TriamcinoloneNystatin/Triamcinolone Acet15$328
Oxybutynin Chloride14$160
Fluconazole16$116
Triamcinolone Acetonide11$65

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Henrico

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →